.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Fuji
Express Scripts
Fish and Richardson
Boehringer Ingelheim
Cipla
Colorcon
McKinsey
AstraZeneca
Daiichi Sankyo

Generated: November 20, 2017

DrugPatentWatch Database Preview

Hospira Inc Company Profile

« Back to Dashboard

What is the competitive landscape for HOSPIRA INC, and what generic and branded alternatives to HOSPIRA INC drugs are available?

HOSPIRA INC has eighty approved drugs.

There are four tentative approvals on HOSPIRA INC drugs.

Summary for Hospira Inc

US Patents:0
Tradenames:60
Ingredients:49
NDAs:80
Drug Master File Entries: 31
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc
MAGNESIUM SULFATE
magnesium sulfate
SOLUTION;INTRAMUSCULAR, INTRAVENOUS202411-001May 14, 2015RXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
SODIUM BICARBONATE
sodium bicarbonate
INJECTABLE;INJECTION202494-002Mar 6, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
CEFOXITIN
cefoxitin sodium
INJECTABLE;INJECTION065313-001Jan 23, 2006APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
CEFUROXIME SODIUM
cefuroxime sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065483-001Oct 15, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
MEROPENEM
meropenem
INJECTABLE;INJECTION090940-001Jun 22, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
HEPARIN SODIUM
heparin sodium
INJECTABLE;INJECTION090571-002Aug 31, 2009APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
HYDROMORPHONE HYDROCHLORIDE
hydromorphone hydrochloride
INJECTABLE;INJECTION200403-003Dec 1, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
DOCETAXEL
docetaxel
INJECTABLE;INJECTION022234-004Jun 23, 2016RXYesNo► Subscribe► Subscribe► Subscribe
Hospira Inc
BIVALIRUDIN
bivalirudin
INJECTABLE;INTRAVENOUS090811-001Jul 14, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
GEMCITABINE HYDROCHLORIDE
gemcitabine hydrochloride
INJECTABLE;INJECTION079183-001Nov 15, 2010APRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Hospira Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hospira Inc
NIPENT
pentostatin
INJECTABLE;INJECTION020122-001Oct 11, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for HOSPIRA INC drugs

Drugname Dosage Strength Tradename Submissiondate
argatroban in sodium chloride
Injection1 mg/mL, 50 mL vials
ARGATROBAN
12/16/2011
argatroban
Injection100 mg/mL, 2.5 mL vials
ARGATROBAN
9/24/2007

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
US Army
Accenture
McKinsey
Healthtrust
Cerilliant
UBS
Novartis
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot